Previous Page
12-01 :: January 2012
nanotimes
Companies Facts
mer – you or me.” nanoRETE is backed by Michigan Accelerator Fund I, a Grand Rapids, Mich., USA, investment partnership focused on Michigan-based early stage life science and technology companies.
panel, is currently under FDA review. Recently, Nanosphere obtained CE-IVD Mark for regulatory approval of the full BC-GP test as an in vitro dia- gnostic in Europe.
In a single automated test, the Verigene BC-S test provides detection of Staphylococcus aureus, Staphy- lococcus epidermidis, and the mecA gene.
Biosensor chips for use in handheld devices for detecting biohazards in the field, developed by biosystems and agri- cultural engineering professor Evangelyn Alocilja. © Kurt Stepnitz / nanoRETE
http://www.nanorete.com N gene®
anosphere, Inc. (NASDAQ: NSPH) has received 510(k) clearance from the FDA for the Veri- Staphylococcus Blood Culture Nucleic Acid
Test (BC-S). The BC-S test expands Nanosphere‘s in- fectious disease test capabilities to include the rapid detection of bacteria that cause deadly bloodstream infections. The Verigene BC-S test was submitted to the FDA as the first phase of a stepwise process to obtain clearance for a larger test panel which will be marketed as the Verigene BC-GP test. The test will be comprised of up to 16 bacterial/resistance marker targets, all on a single test cartridge. A second 510(k), needed to obtain clearance for the full BC-GP test
anostart AG (OTCQX: NASRY) has acquired two shares in its equity investment Holmenkol AG
from co-shareholder Nanogate (N7G.FSE). It now holds 50% plus one share, giving it a majority stake in Holmenkol. The transaction was approved at the Annual General Meeting of Holmenkol on December 9, 2011, and has now been carried out. Marco Beck- mann, CEO of Nanostart, commented: “Nanostart has always been convinced of the capabilities of Hol- menkol, which is why we acted quickly to exercise our preemption right.”
aturalNano (OTCBB: NNAN.OB) and Sparta Armor have entered into an exclusive Joint
Development and Supply Agreement to utilize their combined technologies. NaturalNano and Sparta Armor will develop a range of products and applica-
tions that combine their respective patented technologies to create a new class of high perfor- mance additives. These will significantly improve the mechanical properties of Sparta‘s Vehicle and Body Armor materials. Under the agreement,
33